Fig. 2From: Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patientsChange of eGFR at the end of 3-years of treatment and 1 year after the treatment in LdT and ETV groups compared to the baselineBack to article page